Lactose (India) Ltd | 152 Cr. | 121 | 247/84.3 | 34.6 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,528 Cr. | 415 | 434/192 | 102 | 22.8 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 31.3 Cr. | 42.2 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.3 Cr. | 20.0 | 29.1/17.0 | 30.6 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 61.4 Cr. | 81.6 | 142/79.0 | 16.2 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 54,728 Cr. | 1,936 | 2,286/1,275 | 41.1 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 276 Cr. | 12.1 | 24.4/10.8 | 16.8 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 672 Cr. | 1,423 | 1,455/635 | 28.7 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 108 Cr. | 21.5 | 32.0/15.0 | 32.9 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 889 Cr. | 302 | 449/219 | 8.51 | 123 | 0.83 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.1 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 10.8 Cr. | 4.33 | 9.28/2.11 | 120 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 379 Cr. | 390 | 477/112 | 61.0 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,935 Cr. | 1,134 | 1,584/1,045 | 48.1 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 92.0 Cr. | 0.45 | 1.24/0.45 | 6.05 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 54.7 Cr. | 22.7 | 26.3/6.40 | 56.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.1 Cr. | 10.0 | 17.3/9.61 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 190 Cr. | 531 | 961/443 | 10.3 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 68.0 Cr. | 68.0 | 71.0/26.1 | 174 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.8 Cr. | 43.4 | 88.7/37.9 | 41.3 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 13.1 Cr. | 5.24 | 5.24/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 20.2 Cr. | 135 | 154/62.5 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 29.5 Cr. | 53.9 | 53.9/9.41 | 328 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 32.4 Cr. | 43.0 | 80.0/0.00 | 45.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.16 Cr. | 20.6 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,535 Cr. | 664 | 1,028/464 | 32.2 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 90.8 Cr. | 21.0 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.2 Cr. | 22.0 | 44.0/17.4 | 48.5 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 286 Cr. | 497 | 524/241 | 30.0 | 119 | 0.91 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 62.2 Cr. | 43.3 | 62.6/31.6 | 56.0 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 65,678 Cr. | 1,120 | 1,530/994 | 19.4 | 557 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 137 Cr. | 220 | 303/170 | 199 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 813 Cr. | 81.0 | 123/74.0 | 17.6 | 32.5 | 1.85 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 43.0 Cr. | 32.9 | 53.2/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 11,464 Cr. | 1,402 | 1,530/727 | 60.6 | 160 | 0.11 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 1.45/0.63 | 85.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 270 Cr. | 35.2 | 68.0/30.0 | 14.4 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.98 Cr. | 17.1 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 143 Cr. | 6.05 | 6.57/2.82 | 259 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 63,538 Cr. | 29,925 | 37,000/25,260 | 43.8 | 1,992 | 1.59 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,588 Cr. | 838 | 972/550 | 28.5 | 220 | 0.60 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 237 Cr. | 83.0 | 84.0/31.3 | 56.9 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,420 Cr. | 1,458 | 1,577/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 23,052 Cr. | 1,418 | 1,870/995 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 833 Cr. | 254 | 330/154 | 19.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 616 Cr. | 460 | 568/270 | 13.2 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,438 Cr. | 486 | 950/456 | 27.5 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,636 Cr. | 1,160 | 1,755/991 | 24.3 | 754 | 0.86 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,19,608 Cr. | 3,533 | 3,790/2,886 | 59.2 | 224 | 0.91 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,198 Cr. | 131 | 317/98.0 | | 43.7 | 0.38 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,598 Cr. | 17.0 | 24.0/14.1 | 28.1 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 34,605 Cr. | 905 | 1,360/856 | 98.4 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,762 Cr. | 209 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,00,941 Cr. | 1,671 | 1,925/1,547 | 35.0 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,689 Cr. | 601 | 886/441 | 110 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,438 Cr. | 275 | 360/175 | 34.7 | 75.9 | 0.15 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 339 Cr. | 1,119 | 1,690/956 | 19.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 7,160 Cr. | 367 | 502/265 | 55.7 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,436 Cr. | 216 | 232/111 | 180 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,831 Cr. | 4,699 | 7,090/4,146 | 30.4 | 340 | 2.49 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,891 Cr. | 2,318 | 2,977/1,772 | 37.6 | 321 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,327 Cr. | 6,199 | 6,739/4,863 | 34.4 | 323 | 2.02 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 157 Cr. | 44.5 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,412 Cr. | 5,333 | 6,039/3,701 | 36.1 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 127 Cr. | 103 | 348/81.0 | 8.99 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,670 Cr. | 435 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,796 Cr. | 746 | 1,998/604 | 44.5 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,937 Cr. | 16,316 | 18,100/10,060 | 159 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 318 Cr. | 14.1 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,149 Cr. | 846 | 1,505/660 | 8.92 | 425 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,732 Cr. | 49.8 | 94.5/41.7 | 29.5 | 21.1 | 0.40 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,431 Cr. | 164 | 359/162 | 21.2 | 54.4 | 0.49 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 108 Cr. | 68.8 | 133/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 341 Cr. | 95.5 | 177/90.2 | 45.5 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 87,047 Cr. | 1,906 | 2,403/1,774 | 23.5 | 377 | 0.63 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,048 Cr. | 523 | 980/499 | 12.1 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 46,112 Cr. | 854 | 944/440 | 90.5 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 940 Cr. | 906 | 1,235/596 | 21.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 148 Cr. | 70.3 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 834 Cr. | 173 | 329/154 | 23.9 | 107 | 1.74 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 622 Cr. | 357 | 500/265 | 22.2 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,311 Cr. | 1,086 | 1,310/802 | 35.6 | 393 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,263 Cr. | 1,677 | 1,998/1,303 | 38.3 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,465 Cr. | 221 | 328/175 | 34.4 | 36.1 | 1.13 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,887 Cr. | 1,334 | 1,758/1,168 | 37.9 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,993 Cr. | 102 | 127/57.5 | 28.4 | 57.5 | 0.78 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 769 Cr. | 105 | 134/67.2 | 34.8 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
Indoco Remedies Ltd | 2,652 Cr. | 287 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,058 Cr. | 248 | 465/245 | 48.3 | 102 | 0.56 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,479 Cr. | 1,742 | 2,786/1,243 | 39.4 | 369 | 0.40 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,659 Cr. | 365 | 504/285 | 59.8 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
Granules India Ltd | 13,799 Cr. | 569 | 628/412 | 28.9 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 54,724 Cr. | 1,939 | 2,286/1,275 | 41.1 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,922 Cr. | 2,767 | 3,516/1,921 | 49.6 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,653 Cr. | 1,923 | 2,131/1,200 | 27.9 | 592 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,424 Cr. | 456 | 570/359 | 27.6 | 140 | 1.10 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,768 Cr. | 1,596 | 1,910/1,097 | 56.2 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,567 Cr. | 1,264 | 1,406/1,020 | 18.6 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,611 Cr. | 294 | 322/169 | 38.8 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,26,203 Cr. | 1,562 | 1,615/1,310 | 23.4 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,646 Cr. | 2,057 | 2,641/1,551 | 27.7 | 375 | 0.29 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 369 Cr. | 125 | 203/95.6 | 182 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,686 Cr. | 159 | 191/105 | 15.8 | 99.7 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 67.0 Cr. | 41.2 | 78.0/40.0 | 24.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 47,221 Cr. | 353 | 406/291 | 130 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,747 Cr. | 1,731 | 2,215/1,430 | 38.2 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 133 Cr. | 83.1 | 141/76.3 | 18.6 | 48.6 | 1.44 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 380 Cr. | 159 | 179/67.8 | 37.7 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 23,170 Cr. | 9,262 | 10,691/6,220 | 110 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,041 Cr. | 705 | 843/544 | 37.4 | 113 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 192 Cr. | 91.6 | 137/85.0 | 7.28 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,269 Cr. | 5,454 | 6,319/4,492 | 28.7 | 1,002 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,641 Cr. | 948 | 1,205/725 | 31.4 | 264 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 459 Cr. | 802 | 1,540/763 | 73.0 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,407 Cr. | 2,434 | 3,395/2,022 | 32.7 | 303 | 1.15 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,427 Cr. | 306 | 518/258 | 25.0 | 127 | 1.70 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,733 Cr. | 515 | 575/312 | 26.4 | 136 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,000.22 Cr | 1,173.68 | | 51.09 | 192.71 | 0.33% | 16.15% | 14.90% | 6.18 |